SNP arrays of BT474 Latpatinib and/or Trastuzumab resistant cell lines for copy number analysis.
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83608
下载链接
链接失效反馈官方服务：
资源简介：
Targeting HER2 with lapatinib (L), trastuzumab (T), or the LT combination, is effective in HER2+ breast cancer (BC), but de novo and acquired resistance commonly occur. The purpose of this experiment was to investigate the somatic alterations found in Lapatinib and/or Trastuzumab resistant cells lines. SNP arrays of BT474 cell derivative genomic DNA was performed using HumanOmni2.5-8 BeadChip Kit.
创建时间：
2020-09-22
